Zhilong Hu

Title: Zhilong Hu: Innovator in Pharmaceutical Development

Introduction

Zhilong Hu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment and thrombotic disorders. With a total of 2 patents, his work has garnered attention in the scientific community.

Latest Patents

Zhilong Hu's latest patents include innovative compounds that have potential therapeutic applications. One of his notable inventions is related to CDK inhibitors, which provides a compound represented by specific structural formulas, or a pharmaceutically acceptable salt, or a stereoisomer thereof, useful for treating cancer. Another significant patent is for a quaternary lactam compound, which is utilized in the manufacture of a medicament for the treatment and/or prevention of thrombotic or thromboembolic disorders.

Career Highlights

Throughout his career, Zhilong Hu has worked with reputable companies in the biotechnology sector. He has been associated with Shanghai Meiyue Biotech Development Co., Ltd. and Genentech, Inc., where he has contributed to various research and development projects. His expertise in pharmaceutical innovation has positioned him as a valuable asset in these organizations.

Collaborations

Zhilong Hu has collaborated with several professionals in his field, including notable coworkers such as Shanghai Yu and Yan Feng. These collaborations have further enhanced his research capabilities and have led to advancements in his projects.

Conclusion

Zhilong Hu is a distinguished inventor whose work in pharmaceutical development has the potential to impact cancer treatment and thrombotic disorders significantly. His contributions through his patents and collaborations highlight his commitment to innovation in the field.